Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
PubMed 22962027 TB-4 Phase 1 human safety first-in-human randomized, double-blind, single- and multiple-dose Phase 1 of recombinant human thymosin 4 in healthy volunteers, no serious adverse events: PubMed 34346165
Related analytical guides Related laboratory materials Supplied exclusively for controlled laboratory research
Verrucomicrobia relative abundance was significantly higher in vehicle-treated mice switched from WD to LD compared to both the LD and WD control groups (Fig
Although this area of study is still emerging, it highlights potential new directions for understanding NNMTs role in adipose biology
US$ 27.24
US$ 24.65
US$ 26.32
